The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- Will Take Charge vs. Palace Malice in Whitney
- Del Mar Makes Adjustment to Slow Polytrack
- Perfect at Spa, Sweet Reason Ready for Test
- Clement Hirsch: Iotapa After BC Distaff Slot
- Trainer Joshua Stein Wins in Debut at Sonoma
- CDI Reports Record Second Quarter Revenues
- New York-Bred Palace At Home In Vanderbilt
- Juddmonte Stallions Available to S.H. Mares
- Social Inclusion to Move to Chad Brown
- Tom Amoss Secures 3,000th Training Victory